375 related articles for article (PubMed ID: 27118999)
21. Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma.
Breault JE; Shiina H; Igawa M; Ribeiro-Filho LA; Deguchi M; Enokida H; Urakami S; Terashima M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):557-64. PubMed ID: 15701841
[TBL] [Abstract][Full Text] [Related]
22. DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis.
Tsai MH; Chen WC; Yu SL; Chen CC; Jao TM; Huang CY; Tzeng ST; Yen SJ; Yang YC
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1481-9. PubMed ID: 25968618
[TBL] [Abstract][Full Text] [Related]
23. Pyrosequencing assays to study promoter CpG site methylation of the O6-MGMT, hMLH1, p14ARF, p16INK4a, RASSF1A, and APC1A genes.
Löf-Ohlin ZM; Nilsson TK
Oncol Rep; 2009 Mar; 21(3):721-9. PubMed ID: 19212632
[TBL] [Abstract][Full Text] [Related]
24. RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker.
Nishio M; Sakakura C; Nagata T; Komiyama S; Miyashita A; Hamada T; Kuryu Y; Ikoma H; Kubota T; Kimura A; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Kokuba Y; Sonoyama T; Ida H; Ito K; Chiba T; Ito Y; Otsuji E
Anticancer Res; 2010 Jul; 30(7):2673-82. PubMed ID: 20682997
[TBL] [Abstract][Full Text] [Related]
25. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
[TBL] [Abstract][Full Text] [Related]
26. Methylation-specific PCR.
Ku JL; Jeon YK; Park JG
Methods Mol Biol; 2011; 791():23-32. PubMed ID: 21913069
[TBL] [Abstract][Full Text] [Related]
27. Promoter CpG island methylation markers in colorectal cancer: the road ahead.
Draht MX; Riedl RR; Niessen H; Carvalho B; Meijer GA; Herman JG; van Engeland M; Melotte V; Smits KM
Epigenomics; 2012 Apr; 4(2):179-94. PubMed ID: 22449189
[TBL] [Abstract][Full Text] [Related]
28. Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay.
Yamamoto N; Nakayama T; Kajita M; Miyake T; Iwamoto T; Kim SJ; Sakai A; Ishihara H; Tamaki Y; Noguchi S
Breast Cancer Res Treat; 2012 Feb; 132(1):165-73. PubMed ID: 21594664
[TBL] [Abstract][Full Text] [Related]
29. CpG island methylator phenotype and prognosis of colorectal cancer in Northeast China.
Li X; Hu F; Wang Y; Yao X; Zhang Z; Wang F; Sun G; Cui BB; Dong X; Zhao Y
Biomed Res Int; 2014; 2014():236361. PubMed ID: 25243122
[TBL] [Abstract][Full Text] [Related]
30. Methylation enrichment pyrosequencing: combining the specificity of MSP with validation by pyrosequencing.
Shaw RJ; Akufo-Tetteh EK; Risk JM; Field JK; Liloglou T
Nucleic Acids Res; 2006 Jun; 34(11):e78. PubMed ID: 16807314
[TBL] [Abstract][Full Text] [Related]
31. 5'-CpG island methylation of the LKB1/STK11 promoter and allelic loss at chromosome 19p13.3 in sporadic colorectal cancer.
Trojan J; Brieger A; Raedle J; Esteller M; Zeuzem S
Gut; 2000 Aug; 47(2):272-6. PubMed ID: 10896921
[TBL] [Abstract][Full Text] [Related]
32. CpG Island Methylator Phenotype and Methylation of Wnt Pathway Genes Together Predict Survival in Patients with Colorectal Cancer.
Kim SH; Park KH; Shin SJ; Lee KY; Kim TI; Kim NK; Rha SY; Ahn JB
Yonsei Med J; 2018 Jul; 59(5):588-594. PubMed ID: 29869456
[TBL] [Abstract][Full Text] [Related]
33. PCR Techniques in Characterizing DNA Methylation.
Wani K; Aldape KD
Methods Mol Biol; 2016; 1392():177-86. PubMed ID: 26843056
[TBL] [Abstract][Full Text] [Related]
34. Droplet Array Platform for High-Resolution Melt Analysis of DNA Methylation Density.
Athamanolap P; Shin DJ; Wang TH
J Lab Autom; 2014 Jun; 19(3):304-12. PubMed ID: 24114798
[TBL] [Abstract][Full Text] [Related]
35. High-resolution methylation analysis of the hMLH1 promoter in sporadic endometrial and colorectal carcinomas.
Strazzullo M; Cossu A; Baldinu P; Colombino M; Satta MP; Tanda F; De Bonis ML; Cerase A; D'Urso M; D'Esposito M; Palmieri G
Cancer; 2003 Oct; 98(7):1540-6. PubMed ID: 14508843
[TBL] [Abstract][Full Text] [Related]
36. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas.
Ye C; Shrubsole MJ; Cai Q; Ness R; Grady WM; Smalley W; Cai H; Washington K; Zheng W
Oncol Rep; 2006 Aug; 16(2):429-35. PubMed ID: 16820927
[TBL] [Abstract][Full Text] [Related]
37. [Correlation of CpG methylation status of Runx3 with pathogenesis of gastric carcinoma].
Tang GH; Sun SW; He XS
Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):314-9. PubMed ID: 22883670
[TBL] [Abstract][Full Text] [Related]
38. Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients Identified by Using a Genome-Wide High-Resolution Array.
Lin PC; Lin JK; Lin CH; Lin HH; Yang SH; Jiang JK; Chen WS; Chou CC; Tsai SF; Chang SC
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1419-27. PubMed ID: 25472652
[TBL] [Abstract][Full Text] [Related]
39. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
[TBL] [Abstract][Full Text] [Related]
40. [Correlation of methylation of CpG island in cystathionine beta synthase promoter and clinicopathological features in colorectal cancer].
Tu XH; Huang SX; Li WS; Song JX
Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):351-5. PubMed ID: 24054011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
